LogoFDA 510(k) Search
Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K221726
    Device Name
    Uni-FuZe-C Bone Strip
    Manufacturer
    Zavation Medical Products, LLC
    Date Cleared
    2023-01-18

    (218 days)

    Product Code
    MQV
    Regulation Number
    888.3045
    Type
    Traditional
    Panel
    Orthopedic
    Reference & Predicate Devices
    K051386,K082166,K201781
    Why did this record match?
    Device Name :

    Uni-FuZe-C Bone Strip

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    Uni-FuZe-C Bone Strip is an implant intended to fill bony voids or gaps of the skeletal system (i.e., extremities and pelvis). These osseous defects are surgically created or the result of traumatic injury to the bone and are not intrinsic to the stability of the bony structure. Uni-FuZe-C Bone Strip resorbs and is replaced with bone during process.

    Device Description

    Zavation Medical's Uni-FuZe-C Bone Strip is a bioactive osteoconductive, resorbable, biocompatible bone graft substitute in strip form. The product is composed of a matrix of purified bovine collagen per ASTM F2212, beta tricalcium phosphate (Beta-TCP per ASTM F1088), and Bioglass 45S5 per ASTM F1538.

    AI/ML Overview

    The provided text describes the 510(k) summary for Zavation Uni-FuZe-C Bone Strip (K221726) and focuses on demonstrating its substantial equivalence to predicate devices, rather than establishing acceptance criteria or reporting on a study directly proving the device meets those criteria in a typical AI/software context.

    However, based on the information provided, we can infer performance criteria related to the device's biological and physical characteristics and how they were evaluated.

    1. A table of acceptance criteria and the reported device performance

    Acceptance Criteria CategorySpecific Acceptance Criteria (Inferred from regulatory requirements and testing)Reported Device Performance (Summary of results)
    BiocompatibilityAcceptable biological safety profiles (per ISO 10993-1:2018 and FDA Guidance)Demonstrated acceptable biological safety profiles (Material-Mediated Pyrogenicity, Cytotoxicity, Irritation, Systemic reaction, Implantation tests).
    Material CompositionMeeting specific ASTM standards for constituentsBioactive glass, collagen, and ß-TCP constituents tested and/or certified to meet ASTM F2212, ASTM F1538, and ASTM F1088 requirements.
    Biological Performance (In-vivo)Normal osteoconductive healing response; absence of adverse inflammatory reactions; substantially equivalent performance to predicate.Macro observations showed healthy tissue absent of adverse inflammatory reactions. Radiographic and microCT analyses indicated no adverse reactions and a normal progression in healing. Histopathology showed normal osteoconductive healing response. Demonstrated substantially equivalent in vivo performance to the primary predicate device across all endpoints.
    BioactivityPrecipitation of apatite during in-vitro assessment (per ISO 23317)Determined to be bioactive per ISO 23317, with bioactive glass granules precipitating apatite in SBF.
    Packaging IntegrityMeeting acceptance criteria for seal strength and integrityPackaging seal strength and integrity validated via peel strength (ASTM F88/F88M) and bubble emission (ASTM F2096); acceptance criteria were met.
    Shipping & HandlingMeeting acceptance criteria for shipping and handling validationShipping and handling validations performed per ASTM D7386; acceptance criteria were met.
    Shelf LifeValidated for the specified durationShelf life validated for one-year.
    SterilizationMeeting specified SAL and endotoxin levelsSterilization validated to SAL of 10° using VDmax method per ANSI/AAMI/ISO 11137-2: 2013/(R)2019 with 25 kGy minimum dose. LAL testing showed
    Ask a Question

    Ask a specific question about this device

    Page 1 of 1